Plant milk vitamin D fortification: a processing roadmap

The critical failure points are dispersion, phase partitioning, mineral interaction, light exposure, and uncontrolled loss between dosing and final packaging.

Vitamin D3 is lipophilic. Most plant-based milk systems are aqueous suspensions with variable oil, protein, starch, fiber, and mineral content. The result is a formulation that can meet the nominal dosing target while producing non-uniform vitamin distribution and lower bioavailability yield. A bottle sampled from the top of a poorly homogenized tank may not represent the vitamin concentration at the bottom.

The production route must therefore be designed as a delivery system. The question is not simply how much vitamin D3 to add. It is where the compound resides in the matrix, how it survives thermal processing, how it interacts with calcium, and whether the consumer receives it in a physically accessible form.

The first constraint: vitamin D3 does not disperse naturally in water

Plant milk is commonly built from water, a plant-derived base, oil or other lipid components, proteins, carbohydrates, stabilizers, minerals, and flavoring systems. Vitamin D3 does not dissolve effectively in the aqueous phase. It requires a carrier phase or a delivery structure that can distribute it through the product.

This creates several process risks:

• Phase partitioning. Vitamin D3 can migrate preferentially into the oil phase or attach to other hydrophobic components. The measured concentration then depends on sampling location and mixing history.
• Incomplete homogenization. A vitamin premix may remain as localized droplets or aggregates rather than forming a stable distribution throughout the beverage.
• Sedimentation and creaming. The plant matrix may separate during storage. Any separation process can move the vitamin with the phase in which it is concentrated.
• Interaction with proteins and polysaccharides. These components can either support dispersion or immobilize the vitamin in a structure that reduces release during digestion.
• Light-driven degradation. Vitamin D3 is sensitive to photo-degradation. Transparent or poorly protective packaging increases the risk after processing.
• Contact with packaging materials. Sorption or migration effects can reduce the measurable concentration over shelf life.

These mechanisms differ between oat, almond, soy, and pea-based beverages. Oat systems often contain starch-derived solids and soluble fibers. Almond systems may contain a lower protein fraction and a more pronounced oil phase. Soy and pea systems provide more protein but can create different interfacial and aggregation behavior. A single overage strategy cannot be transferred between these matrices without validation.

Vitamin D2 or vitamin D3?

For most fortification programs, vitamin D3, or cholecalciferol, is the preferred compound. It generally has higher potency and greater efficacy in raising serum 25-hydroxyvitamin D concentrations than vitamin D2, ergocalciferol.

A plant-based product does not require vitamin D2 merely because its base is vegan. Lichen-derived vitamin D3 provides a vegan-compliant alternative to conventional lanolin-derived D3. The source decision is therefore separate from the physical processing decision. The formulation still requires a stable carrier, controlled dosing, and validated distribution.

The limiting operation is usually not thermal exposure. It is the physical placement of vitamin D3 inside a multiphase beverage.

Plant milk enrichment process milestones

A functional fortification process begins before the vitamin enters the tank. The premix, addition point, shear conditions, and sampling plan determine whether the declared dose is technically achievable.

A practical sequence contains the following milestones.

1. Define the nutrient target and analytical basis

The target must be expressed as a concentration in the finished product, not only as an addition rate to the process tank. The formulation team must define:

• the intended vitamin D3 level per serving or per unit mass;
• the regulatory nutrient declaration required in the target market;
• the expected process and storage losses;
• the analytical method used to verify vitamin D3;
• the acceptable batch-to-batch variation;
• the interaction between vitamin D3 dosing and calcium fortification.

The declared value and the manufacturing target are not necessarily identical. The manufacturing target may require a controlled overage because vitamin D3 can decline during storage or become analytically unavailable. The overage must be established from stability data for the specific matrix and package. There is no universal percentage that applies to every plant milk.

2. Select the vitamin D3 delivery form

Available forms include oil-based concentrates, water-dispersible preparations, emulsified systems, and encapsulated powders or liquids. The choice depends on the plant milk’s composition and the available equipment.

An oil-based concentrate may be adequate when the beverage already contains a stable lipid phase and the homogenization system can reduce droplet size consistently. It is less suitable when the final product is extremely low in fat or when the oil phase is unstable.

A water-dispersible preparation can simplify dosing into an aqueous system. However, apparent water dispersibility does not guarantee long-term stability. The carrier may still separate, adsorb to solids, or release vitamin D3 during thermal processing.

Encapsulated systems use a wall material or matrix to isolate vitamin D3 from the surrounding environment. Starch and protein complex matrices are among the approaches used to protect the compound and improve distribution. Their performance depends on encapsulation efficiency, particle size, wall integrity, and compatibility with the beverage.

3. Prepare the premix under controlled shear

The vitamin concentrate should not be poured directly into a large production tank and expected to distribute uniformly. A premix is first prepared in a controlled carrier phase. The carrier may include part of the formulation water, a compatible oil phase, or an emulsifying system.

The premix stage controls the initial droplet or particle distribution. It also limits local concentration spikes. Localized high concentrations can increase adsorption to vessel surfaces, destabilize the emulsion, or create analytical variability.

Ultrasonic emulsification can produce a fine dispersion and support microencapsulation. The exact outcome depends on energy input, formulation viscosity, solids content, temperature, and residence time. Ultrasonic treatment is not a substitute for formulation design. Excessive energy can produce heating or damage other matrix components.

4. Dose at a defined process point

The addition point must provide enough downstream mixing to distribute vitamin D3 but avoid unnecessary exposure to light, oxygen, and high-shear recirculation. Dosing before homogenization can allow the homogenizer to break down the vitamin-containing droplets. Dosing after homogenization may reduce mechanical stress but can produce inadequate distribution if the final mixing stage is weak.

The correct location depends on the specific line. It must be established with concentration mapping across the tank and, where relevant, across the filling system. Samples should not be taken from one convenient valve and treated as representative without evidence.

5. Homogenize and verify phase stability

Homogenization reduces droplet size and narrows the distribution of the dispersed phase. It can improve physical stability and reduce creaming. It does not automatically increase vitamin D3 bioavailability. A smaller droplet can improve gastrointestinal access, but the result depends on the complete digestion environment and the composition of the carrier.

Homogenization pressure, number of stages, temperature, and formulation solids affect the final structure. These variables should be linked to measurements of:

• vitamin D3 concentration at multiple tank locations;
• particle or droplet size distribution;
• visible creaming or sedimentation;
• viscosity and flow behavior;
• calcium and protein stability;
• vitamin retention during storage.

Thermal processing dynamics: HTST versus UHT

Vitamin D3 has high thermal stability during standard pasteurization. In a conventional high-temperature short-time process, a representative condition is 72 °C for 15 seconds. This treatment is not expected to destroy the majority of the vitamin.

The main risk is not the pasteurization temperature alone. It is what happens to the vitamin-containing structure during and after thermal treatment. A carrier can destabilize. A droplet can coalesce. A protein complex can change its binding behavior. A mineral suspension can alter viscosity and sedimentation. These effects influence the measured vitamin concentration even when the vitamin molecule itself remains relatively heat-stable.

UHT plant milk is commonly processed in the range of 135–150 °C for a short residence time. The temperature is higher, but the exposure period is brief. The final retention depends on the product’s pH, oxygen level, solids content, carrier structure, processing equipment, and package.

The following comparison is useful for process design:

The UHT route requires a larger systems view. The vitamin must survive the thermal step, but it must also remain associated with the intended phase during months of storage. An acceptable result immediately after filling does not establish an acceptable result at the end of shelf life.

Why post-dosing losses are often more important

Vitamin D3 loss can occur after dosing through several non-thermal mechanisms. Incomplete homogenization leaves the vitamin unevenly distributed. Phase separation moves the vitamin into a concentrated fraction. Light exposure initiates photo-degradation. Packaging contact can reduce recovery in the finished product.

This distinction matters operationally. Increasing the vitamin dose may compensate for a known storage loss, but it will not correct poor distribution. A batch with an excessive nominal dose can still contain under-fortified portions if the premix separates or remains localized.

The correct sequence is:

1. establish a uniform initial distribution;

2. confirm physical stability;

3. measure retention through thermal processing;

4. evaluate retention in the final package;

5. determine the manufacturing target and any necessary overage.

Calcium and vitamin D co-fortification

Plant-based milks naturally lack several micronutrients found in bovine milk. Calcium and vitamin D are therefore frequently added together to produce a more comparable nutritional profile. This combination creates a technical problem because calcium salts can alter the physical environment around vitamin D3.

The issue is not that calcium universally destroys vitamin D. The concern is that calcium fortification can reduce vitamin D bioaccessibility during gastrointestinal digestion. Calcium particles, proteins, emulsifiers, and plant-derived solids may alter the way the vitamin is released from the food matrix and incorporated into mixed micelles during digestion.

Bioavailability yield therefore cannot be inferred from the label concentration alone. A product may contain the intended vitamin D3 quantity but release a lower proportion under simulated digestion conditions.

Calcium salt selection and matrix response

The calcium source affects suspension stability, mouthfeel, sedimentation, and compatibility with the vitamin delivery system. A highly reactive or poorly dispersed calcium salt can produce localized mineral-rich regions. These regions may interact with proteins or encapsulation walls and change the release profile of vitamin D3.

The formulation must be evaluated as a combined system. Testing vitamin D3 without calcium does not reproduce the finished product. Testing calcium stability without vitamin D3 does not show whether the co-fortified nutrient system is effective.

Relevant measurements include:

• total vitamin D3 concentration;
• fraction released during in vitro digestion;
• calcium sedimentation and particle distribution;
• viscosity changes during storage;
• emulsion or suspension stability;
• nutrient retention at the beginning and end of shelf life.

A finished-product label measures declared content. It does not, by itself, measure the fraction released from the matrix during digestion.

Microencapsulation and nanoemulsification

When conventional premixing does not provide sufficient stability, the next step is to engineer the vitamin’s physical environment. Microencapsulation and nanoemulsification are two related but distinct approaches.

Microencapsulation

Microencapsulation surrounds vitamin D3 with a protective wall or incorporates it into a structured matrix. Starch and protein complexes can provide a barrier against oxygen, light, and unfavorable interactions with other formulation components.

The technical objectives are straightforward:

• prevent the vitamin from separating into an unstable oil phase;
• reduce direct contact with oxygen and light;
• improve dispersibility in the aqueous beverage;
• control release during digestion;
• maintain concentration through processing and storage.

Reported encapsulation efficiencies using ultrasonic emulsification and starch- or protein-based matrices can exceed 79% and reach more than 89%, depending on the formulation and method. These values are process-specific. They should not be treated as universal performance guarantees.

Retention data are equally dependent on the matrix. One reported approach retained approximately 70% of encapsulated vitamin D3 over eight months when calcium was co-encapsulated. The result demonstrates the potential of the method, not a fixed shelf-life value for every oat, almond, soy, or pea beverage.

A high encapsulation efficiency at the point of manufacture also does not ensure high bioavailability. The wall must remain intact during production but release the vitamin under gastrointestinal conditions. Excessively strong binding can protect the compound and simultaneously reduce its accessibility.

Nanoemulsification

Nanoemulsification reduces the size of vitamin-containing droplets and increases the interfacial area available for interaction with the aqueous phase and digestive components. This can improve apparent dispersibility and may support bioaccessibility.

The process introduces additional control requirements:

• droplet size must remain stable through heating and storage;
• the emulsifier must be compatible with the plant base;
• the system must resist aggregation and coalescence;
• the emulsion must tolerate calcium salts and other minerals;
• the final product must retain acceptable sensory and rheological properties.

Nanoemulsification is not automatically superior to microencapsulation. A nanoemulsion with poor storage stability can perform worse than a larger but better-protected encapsulated particle. The correct choice depends on the failure mechanism observed in the base product.

Choosing the delivery system

Fortifying oat milk with vitamin D: process-specific risks

Oat milk presents a combination of starch-derived solids, soluble fiber, and suspended particles. These components influence viscosity and can affect how a vitamin-containing emulsion moves through the process line.

The main risk is not simply low fat content. It is the interaction between the vitamin carrier and the carbohydrate-rich continuous phase. A poorly selected carrier may be trapped in the solids fraction, migrate with separated oil, or contribute to unstable sedimentation.

A practical oat milk vitamin D fortification sequence is:

1. Hydrate the oat base and establish a stable solids dispersion.

2. Prepare the vitamin D3 premix separately under controlled shear.

3. Add the premix at a point that provides sufficient downstream homogenization.

4. Combine calcium only after confirming that the mineral addition does not destabilize the vitamin carrier.

5. Apply HTST or UHT treatment according to the product route.

6. Fill into packaging with controlled light and oxygen exposure.

7. Map vitamin D3 concentration across the batch and through storage.

The order of calcium and vitamin addition should not be assumed. In some systems, early calcium addition changes viscosity or protein interaction before the vitamin carrier is formed. In others, late mineral addition may produce inadequate dispersion. The sequence must be determined experimentally for the actual formulation.

Almond milk vitamin D fortification steps

Almond beverages often require particular attention to the oil phase and suspended almond solids. The vitamin may preferentially associate with lipids, while the product’s physical stability depends on emulsification and particle suspension.

The process should distinguish between three outcomes:

• the vitamin is uniformly distributed in the continuous beverage;
• the vitamin is concentrated in the lipid fraction but remains physically stable;
• the vitamin follows an unstable phase that creams or sediments during storage.

Only the first two can be acceptable, and the second requires evidence that the product remains uniform after normal handling and that the vitamin is recovered consistently in representative samples.

For almond milk vitamin D fortification, the relevant process controls include premix compatibility, homogenization performance, calcium salt dispersion, package light protection, and storage stability. A single post-filling sample is insufficient. Sampling should cover the production tank, early and late filling, and defined storage intervals.

Packaging and post-dosing degradation

The package is part of the nutrient delivery system. It is not a neutral container.

For refrigerated products, the combination of retail lighting, repeated opening, oxygen ingress, and phase separation can influence vitamin retention. For UHT products, the ambient shelf-life period can extend to 6–12 months. The package must then protect the beverage over a substantially longer exposure window.

Opaque or light-protective packaging reduces photo-degradation risk. Low-oxygen filling and suitable closure systems limit oxidative stress. Package selection should be evaluated with the finished product, not with vitamin D3 in isolation, because plant solids and minerals modify the internal environment.

Stability testing should include:

• vitamin D3 content at release;
• retention at defined storage intervals;
• package orientation where separation is possible;
• exposure to expected light conditions;
• physical stability of the beverage;
• end-of-shelf-life nutrient uniformity;
• comparison between total content and digestion-released content where bioaccessibility is a product claim.

The analytical method must also be suitable for the matrix. Plant proteins, oils, pigments, and minerals can interfere with extraction or detection. Method recovery should be established using the finished beverage rather than a simple solvent standard.

Building the validation plan

A production roadmap is incomplete without a validation structure. The objective is to connect each processing variable with a measurable nutrient outcome.

A useful validation sequence contains five stages:

1. Bench formulation. Compare vitamin D3 delivery forms in the actual plant base. Include calcium at the intended concentration.

2. Pilot homogenization. Test premix order, shear, and addition point. Measure uniformity and physical stability.

3. Thermal challenge. Process the formulation through the intended HTST or UHT route. Compare pre- and post-treatment vitamin D3 recovery.

4. Package study. Fill the product into the intended container and evaluate light, oxygen, and storage effects.

5. Digestion assessment. Measure whether the retained vitamin is released under an in vitro gastrointestinal model.

The sequence avoids a common error: selecting a delivery system based only on initial assay results. Initial recovery is necessary. It is not sufficient.

The plant milk enrichment process milestones should be recorded as manufacturing controls rather than treated as laboratory observations. Premix temperature, mixing time, shear conditions, dosing rate, homogenization parameters, and filling conditions all affect the final nutrient distribution. If these parameters drift, vitamin D3 performance can drift with them.

The practical decision

For a standard refrigerated plant milk with a stable lipid phase, a conventional vitamin D3 emulsion may be adequate if homogenization and packaging are well controlled. For a low-fat or highly aqueous product, a water-dispersible or encapsulated form is more defensible. For UHT products with long ambient shelf life, matrix encapsulation and light-protective packaging provide stronger control over post-processing degradation.

The cost-benefit calculation is strict:

• Basic premix systems have lower material and process costs but depend heavily on homogenization and phase stability.
• Emulsified systems improve dispersion and may fit existing equipment, but they require control of droplet stability and mineral compatibility.
• Microencapsulation increases formulation and analytical complexity, but it offers stronger protection against light, oxygen, and phase partitioning.
• Nanoemulsification can improve dispersibility and potential bioaccessibility, but it requires tighter control of droplet size, emulsifier selection, and long-term stability.
• Protective packaging adds material cost but can prevent losses that cannot be corrected by additional dosing.

The preferred system is therefore the least complex technology that controls the observed failure mechanism. Vitamin D3 fortification in plant milk production should not be optimized by dose alone. It should be optimized by distribution, retention, release, and verified end-of-shelf-life performance.

A product is technically fortified only when the nutrient remains uniformly present, chemically recoverable, physically stable, and sufficiently accessible from the finished matrix. That is the complete process requirement.